pelanserin

N/A

Report date: 2025/04/25 09:36:49
NME

Base Information

Drug Namepelanserin
Drug Alias Namepelanserin hydrochlorideTR-2515
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptor alpha-1 agonistsSerotonin 2 (5-HT2) receptor antagonists
TargetsAdrenergic receptors alpha-1Serotonin 2a (5-HT2a) receptorSerotonin 2 (5-HT2) receptor
Therapy Area/IndicationsSchizophreniaPsychotic Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMexico
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCinvestav
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCinvestav
Active IndicationsN/A
Inactive IndicationsSchizophreniaPsychotic Disorders

Other Information

ATC CodeN/A
Related LinksN/A